Yayın:
PO-35 - Designing of the new antithrombotic and also anticancer gold complexes

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBenkli, Kadriye
dc.contributor.orcid0000-0002-9042-8718
dc.date.accessioned2025-11-13T22:20:02Z
dc.date.issued2016-04-01
dc.identifier.doihttps://doi.org/10.1016/s0049-3848(16)30168-2
dc.identifier.endpageS189
dc.identifier.issn0049-3848
dc.identifier.openalexW2315416780
dc.identifier.startpageS189
dc.identifier.urihttps://hdl.handle.net/11421/13842
dc.identifier.urihttps://doi.org/10.1016/s0049-3848(16)30168-2
dc.identifier.volume140
dc.language.isoen
dc.relation.ispartofThrombosis Research
dc.rightsrestrictedAccess
dc.subjectP2Y12
dc.subjectPrasugrel
dc.subjectPharmacology
dc.subjectAngiogenesis
dc.subjectChemistry
dc.subjectCancer research
dc.subjectPlatelet
dc.subjectMedicine
dc.subjectBiochemistry
dc.subjectInternal medicine
dc.subjectPlatelet aggregation
dc.subjectClopidogrel
dc.subject.sdg3
dc.titlePO-35 - Designing of the new antithrombotic and also anticancer gold complexes
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5040026405

Dosyalar

Koleksiyonlar

Publications